193 related articles for article (PubMed ID: 35019598)
1. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering.
Nabavinia M; Beltran-Huarac J
ACS Appl Bio Mater; 2020 Dec; 3(12):8172-8187. PubMed ID: 35019598
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
3. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia.
Dias AMM; Courteau A; Bellaye PS; Kohli E; Oudot A; Doulain PE; Petitot C; Walker PM; Decréau R; Collin B
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365207
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
6. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Control of Protein Expression via Magneto-mechanical Actuation of ND-PEGylated Iron Oxide Nanocubes for Cell Therapy.
Beltran-Huarac J; Yamaleyeva DN; Dotti G; Hingtgen S; Sokolsky-Papkov M; Kabanov AV
ACS Appl Mater Interfaces; 2023 Apr; 15(16):19877-19891. PubMed ID: 37040569
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Pernal S; Wu VM; Uskoković V
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
[TBL] [Abstract][Full Text] [Related]
10. Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy.
Vangijzegem T; Lecomte V; Ternad I; Van Leuven L; Muller RN; Stanicki D; Laurent S
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678868
[TBL] [Abstract][Full Text] [Related]
11. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
12. In Situ Biosynthesized Superparamagnetic Iron Oxide Nanoparticles (SPIONS) Induce Efficient Hyperthermia in Cancer Cells.
Kaushik S; Thomas J; Panwar V; Ali H; Chopra V; Sharma A; Tomar R; Ghosh D
ACS Appl Bio Mater; 2020 Feb; 3(2):779-788. PubMed ID: 35019282
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
Mohammad F; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
[TBL] [Abstract][Full Text] [Related]
14. Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy.
Janko C; Ratschker T; Nguyen K; Zschiesche L; Tietze R; Lyer S; Alexiou C
Front Oncol; 2019; 9():59. PubMed ID: 30815389
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
17. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic iron oxide nanoparticles (SPIONs) as a multifunctional tool in various cancer therapies.
Musielak M; Piotrowski I; Suchorska WM
Rep Pract Oncol Radiother; 2019; 24(4):307-314. PubMed ID: 31193459
[TBL] [Abstract][Full Text] [Related]
20. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
Lin MM; Kim DK; El Haj AJ; Dobson J
IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
